A Cluster Randomized Trial On Cardiovascular Risk Factor Management: Caduet [amlodipine/atorvastatin; Pfizer] Versus Usual Care In Subjects With Hypertension And Additional Cardiovascular Risk Factors In Clinical Practice.

Trial Profile

A Cluster Randomized Trial On Cardiovascular Risk Factor Management: Caduet [amlodipine/atorvastatin; Pfizer] Versus Usual Care In Subjects With Hypertension And Additional Cardiovascular Risk Factors In Clinical Practice.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Jul 2015

At a glance

  • Drugs Amlodipine/atorvastatin (Primary)
  • Indications Coronary disorders; Hypertension
  • Focus Therapeutic Use
  • Acronyms CRUCIAL
  • Sponsors Pfizer
  • Most Recent Events

    • 19 Jun 2010 Results were presented at the 20th European Meeting on Hypertension.
    • 01 Mar 2010 Study rationale and design, and a discussion of the challenges in the design and conduct of this cluster-randomized trial, have been reported in the March 2010 issue of the journal Postgraduate Medicine.
    • 15 Dec 2009 Actual patient number (1531) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top